AMY CHURCH: Open Payments
NPI 1902507056 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 40 payments from 17 companies in 2025. Trend: 2023 $167 · 2024 $593 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $154 |
| ABIOMED | 4 | $97 |
| Lilly USA, LLC | 4 | $72 |
| SANOFI PASTEUR INC. | 2 | $55 |
| Astellas Pharma US Inc | 3 | $52 |
| Amgen Inc. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
Products named: MOUNJARO, Ozempic, Rybelsus, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Veozah, EVENITY, LEQVIO, Auvelity.
Industry payments across KS — which companies pay providers there.
